217 related articles for article (PubMed ID: 9624486)
1. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations.
Johnson EM; Ojwang JO; Szekely A; Wallace TL; Warnock DW
Antimicrob Agents Chemother; 1998 Jun; 42(6):1412-6. PubMed ID: 9624486
[TBL] [Abstract][Full Text] [Related]
2. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga MT; Miranda Y; del Valle O; Cossum PA; Wallace TL
J Antimicrob Chemother; 1999 Sep; 44(3):397-401. PubMed ID: 10511410
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.
Arikan S; Ostrosky-Zeichner L; Lozano-Chiu M; Paetznick V; Gordon D; Wallace T; Rex JH
J Clin Microbiol; 2002 Apr; 40(4):1406-12. PubMed ID: 11923365
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole.
Oakley KL; Moore CB; Denning DW
Antimicrob Agents Chemother; 1999 May; 43(5):1264-6. PubMed ID: 10223948
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages.
González GM; Tijerina R; Sutton DA; Graybill JR; Rinaldi MG
Antimicrob Agents Chemother; 2002 May; 46(5):1583-5. PubMed ID: 11959606
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
Espinel-Ingroff A
J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae.
Lass-Flörl C; Nagl M; Gunsilius E; Speth C; Ulmer H; Würzner R
Mycoses; 2002 Jun; 45(5-6):166-9. PubMed ID: 12100533
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of NS-718, a novel lipid nanosphere-encapsulated amphotericin B, against Cryptococcus neoformans.
Hossain MA; Maesaki S; Kakeya H; Noda T; Yanagihara K; Sasaki E; Hirakata Y; Tomono K; Tashiro T; Kohno S
Antimicrob Agents Chemother; 1998 Jul; 42(7):1722-5. PubMed ID: 9661011
[TBL] [Abstract][Full Text] [Related]
11. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
Warnock DW; Johnson EM; Rogers TR
J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
[TBL] [Abstract][Full Text] [Related]
12. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves.
Ralph ED; Khazindar AM; Barber KR; Grant CW
Antimicrob Agents Chemother; 1991 Jan; 35(1):188-91. PubMed ID: 2014976
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of a liposomal nystatin formulation (Nyotran) against Cryptococcus neoformans].
Alonso-Vargas R; González-Alvarez L; Ruesga MT; Carrillo-Muñoz AJ; Martín-Mazuelos E; Wallace TL; Cossum PA; Pontón J; Quindós G
Rev Iberoam Micol; 2000 Sep; 17(3):90-2. PubMed ID: 15762799
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities of Zygomycota to polyenes.
Dannaoui E; Meis JF; Mouton JW; Verweij PE;
J Antimicrob Chemother; 2002 May; 49(5):741-4. PubMed ID: 12003966
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
[TBL] [Abstract][Full Text] [Related]
18. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study.
Jessup C; Reyes G; Fothergill A; McCarthy D; Rinaldi M; Messer S; Pfaller M; Ghannoum M
J Chemother; 2000 Feb; 12(1):22-9. PubMed ID: 10768512
[TBL] [Abstract][Full Text] [Related]
19. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
